Sionna Therapeutics Q3 Earnings Preview
Sionna Therapeutics is scheduled to report Q3 results on November 11. Revenue is estimated at zero, with EPS anticipated at (0.64) USD.
Related stories
Nooks Secures $500M and Launches AI Sales Assistant Node
M impact | EQUITY | Nov 04, 2026, 02:10 PM UTC
Algoma Central Closes $70 Million Convertible Debenture Financing
Algoma Central closed its previously announced offering of $70 million in 6.20% convertible unsecured subordinated debentures, priced at $1,000 each.
M impact | EQUITY | Nov 04, 2026, 01:55 PM UTC
Algoma Central Closes $90 Million Convertible Debenture Financing
M impact | EQUITY | Nov 04, 2026, 01:55 PM UTC
Seacon Shipping Agrees to Acquire Vessel for $19.60 Million
Seacon Shipping announced a vessel acquisition agreement valued at USD 19.60 million.
M impact | EQUITY | Nov 04, 2026, 01:54 PM UTC
Sequoia Capital to Close London Office, Raises About $10 Billion
M impact | EQUITY | Nov 04, 2026, 01:54 PM UTC
Atlanta Braves Q3 Earnings Fall as Revenue Rises
Atlanta Braves reported lower Q3 earnings and higher revenue.
M impact | EQUITY | Nov 04, 2026, 01:54 PM UTC